These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29193915)

  • 1. Cervical cancer screening in Brazil according to economic income.
    Kraft Rovere R; Silva de Lima A; Fernanda Hilgert S; Louise Cidral D
    Bol Asoc Med P R; 2016; 108(1):37-39. PubMed ID: 29193915
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.
    Vanni T; Luz PM; Grinsztejn B; Veloso VG; Foss A; Mesa-Frias M; Legood R
    Int J Cancer; 2012 Jul; 131(2):E96-104. PubMed ID: 21964797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.
    Campos NG; Tsu V; Jeronimo J; Mvundura M; Lee K; Kim JJ
    Int J Cancer; 2017 Mar; 140(6):1293-1305. PubMed ID: 27925175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in Santiago Atitlán, Guatemala.
    Frey MK; Roselli N; Gertz E; Cuc JC; Boyd L; Shirazian T
    Int J Gynaecol Obstet; 2016 Oct; 135(1):119. PubMed ID: 27451397
    [No Abstract]   [Full Text] [Related]  

  • 5. To what extent is women's economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010.
    Menvielle G; Richard JB; Ringa V; Dray-Spira R; Beck F
    Cancer Causes Control; 2014 Aug; 25(8):977-83. PubMed ID: 24842393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening with acetic acid could prevent 22 000 deaths from cervical cancer in India every year.
    Kay M
    BMJ; 2013 Jun; 346():f3935. PubMed ID: 23775857
    [No Abstract]   [Full Text] [Related]  

  • 7. Saving the World's Women from Cervical Cancer.
    Tsu V; Jerónimo J
    N Engl J Med; 2016 Jun; 374(26):2509-11. PubMed ID: 27355529
    [No Abstract]   [Full Text] [Related]  

  • 8. Cervical Cancer Screening in Low-Resource Settings.
    Elit L; Ogilvie G; Lee M
    J Obstet Gynaecol Can; 2017 Dec; 39(12):1183-1184. PubMed ID: 29197485
    [No Abstract]   [Full Text] [Related]  

  • 9. [Are we ready for the growing threat of virus dependent cervical cancer and the initiation of screening in conditions of insurance medicine?].
    Cherenkov VG; Petrov AB; Ivanchenko OG; Chistiakova TV; Aleksandrov AS; Ivanova VV
    Vopr Onkol; 2014; 60(4):517-21. PubMed ID: 25552076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global strategies for cervical cancer prevention and screening.
    Pimple SA; Mishra GA
    Minerva Ginecol; 2019 Aug; 71(4):313-320. PubMed ID: 30808155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to increase cervical cancer screening rates.
    Hitzeman N; Xavier EM
    Am Fam Physician; 2012 Mar; 85(5):443-5. PubMed ID: 22534220
    [No Abstract]   [Full Text] [Related]  

  • 12. [A review of health economic evaluation on cervical cancer screening by visual inspection with acetic acid].
    Shi JF; Xiang W; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jan; 30(1):87-90. PubMed ID: 19565857
    [No Abstract]   [Full Text] [Related]  

  • 13. Early prevention and screening of cervical cancer in a developing country.
    Carvallo-Michelena A; Rojas-Dominguez JL; Piscoya A
    Am J Prev Med; 2015 Mar; 48(3):e1. PubMed ID: 25701946
    [No Abstract]   [Full Text] [Related]  

  • 14. [IS THERE A PLACE FOR VIA AND VILI IN OUR PRACTICE].
    Zlatkov V
    Akush Ginekol (Sofiia); 2016; 55 Suppl 1 Pt 2():29-35. PubMed ID: 27509667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early prevention and screening of cervical cancer in a developing country-reply.
    Ekwueme DU; Saraiya M
    Am J Prev Med; 2015 Mar; 48(3):e2-3. PubMed ID: 25701947
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china.
    Valdez M; Jeronimo J; Bansil P; Qiao YL; Zhao FH; Chen W; Zhang X; Kang LN; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    Int J Cancer; 2016 Mar; 138(6):1453-61. PubMed ID: 26421807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of integrating cervical cancer screening at an HIV clinic in Kenya.
    Vodicka EL; Babigumira JB; Mann MR; Kosgei RJ; Lee F; Mugo NR; Okech TC; Sakr SR; Garrison LP; Chung MH
    Int J Gynaecol Obstet; 2017 Feb; 136(2):220-228. PubMed ID: 28099724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-benefit analysis of a population-based cervical cancer screening program designed for Cantabria].
    Ramos-Barrón MÁ; Vázquez-Rodríguez JA; García-Garrido AB
    Semergen; 2014 Sep; 40(6):296-304. PubMed ID: 24534799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Screening in Low- and Middle-Income Countries.
    Martinez ME; Schmeler KM; Lajous M; Newman LA
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431272. PubMed ID: 38843475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimizing verification bias in cervical cancer screening of HIV-infected women.
    Bateman AC; Chibwesha CJ; Parham GP
    Int J Gynaecol Obstet; 2015 Mar; 128(3):269-70. PubMed ID: 25467910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.